3B Blackbio DX Ltd Share Price

Q: What is the share price of 3B Blackbio DX Ltd today?

3B Blackbio DX Ltd share price as on 18 Nov 2025 is ₹1339.85

Healthcare

BSE: 532067 Small Cap ISIN: INE994E01018

As on 19 November 2025 at 01:29 IST

₹1,339.85

+ 11.70

(0.88%)

Sell Buy

Over 1 Month

-4.22%

Over 6 Months

-21.86%

Over 1 Year

-20.96%

Over 3 Years

210.97%

3B Blackbio DX Ltd Summary

Close ₹1,328.15

Open ₹1,415

High ₹1,425

Low ₹1,248

Volume 22,072

Net Turnover (in Cr) ₹2.9

52Wk High ₹2,350

52Wk Low ₹1,248

52Wk High / Low

1,248

2,350

3B Blackbio DX Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹1,139.91

EPS (TTM) 58.37

Book Value (BV) 346.18

Div. Yield 0.30 %

P/E (TTM) 22.75

Price/Book Value 3.84

Delivery % 60.58 %

Face Value 10

Key Ratios

PE Ratio 29.13

PB Ratio 5.08

EV to Sales 14.64

PEG Ratio 0.75

ROA 17.42

ROE 19

Debt-Equity -

Net Profit Margin 52.54

Operating Profit Margin 71.68

3B Blackbio DX Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	111.55	86.66	69.10	87.55	229.63
Total Expenses	47.55	42.33	33.79	44.33	77.60
Profit Before Tax	64	44.33	35.31	43.22	152.04
Profit After Tax	47.69	32.10	25.94	32.20	113.87
Operating Profit After Depreciation	64.11	44.46	35.51	43.33	152.26

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	7.22	7.40	7.79	6.61	5
Total Non Current Assets	163.53	124.71	99.82	110.55	75.14
Total Current Assets	132.19	123.39	114.24	81.54	118.38
Total Assets	295.72	248.10	214.06	192.09	193.52
Total Shareholder's Fund	268.42	223.05	193.26	153.02	132.05

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	43.36	26.95	20.28	37.33	97.52
Net Cash Used In Investing Activities	-33.45	-20.38	15.04	-28.44	-70.26
Net Cash Used In Financing Activities	-3.22	-3.63	-5.01	-15.07	-1.57

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	105.56	83.04	66.60	25.62	18.08
Total Expenses	41.63	36.60	30.76	17.15	16
Profit Before Tax	63.93	46.44	35.84	8.46	2.08
Profit After Tax	47.56	34.21	26.42	8.01	1.72
Operating Profit After Depreciation	64.02	46.56	36.04	8.57	2.31

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	6.37	6.53	6.79	3.23	1.97
Total Non Current Assets	173.07	134.23	109.21	7.20	5.97
Total Current Assets	124.05	115.59	104.46	24.40	22.92
Total Assets	297.12	249.82	213.67	31.60	28.89
Total Shareholder's Fund	272.79	227.78	196.09	23.93	22.65

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	44.47	28.47	21.16	7.98	2.79
Net Cash Used In Investing Activities	-33.64	-20.32	-7.80	-1.52	-0.17
Net Cash Used In Financing Activities	-3.07	-3.62	-2.89	-6.31	-1.59

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	33.90	22.23	22.50	25.39	29.15
Total Expenses	19.17	10.40	14.58	10.32	12.97
Profit Before Tax	19.62	15.86	12.54	17.79	19.32
Profit After Tax	15.04	12.64	8.04	13.50	14.86
Operating Profit after Depreciation	20.24	16.15	12.86	18.08	19.62

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	27.91	20.36	23.02	23.43	26.57
Total Expenses	12.07	8.76	13.55	8.46	11.48
Profit Before Tax	19.52	15.68	14.15	17.74	18.27
Profit After Tax	14.94	12.46	9.24	13.45	14.14
Operating Profit after Depreciation	19.75	15.91	14.38	17.98	18.52

3B Blackbio DX Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,242.43

S2 1,156.72

S3 1,065.43

Pivot 1,333.72

R1 1,419.43

R2 1,510.72

R3 1,596.43

Moving Average

20 SMA 1,363.05

50 SMA 1,386.76

100 SMA 1,448.28

200 SMA 1,594.63

3B Blackbio DX Ltd Corporate Actions

3B Blackbio DX Ltd

₹4.0/Share

Announcement Date 19 Sep 2025

Record Date 19 Sep 2025

Div Yield 40%

AGM Date: 22 Sep 2021

INTIMATION OF DATE OF ANNUAL GENERAL MEETING Scrutinizers Report(As Per BSE Announcement Dated on 9/23/2021 1:22:25 AM) Scrutinizers Report(As Per BSE Announcement Dated on 9/23/2021 2:37:52 AM)

AGM Date: 22 Sep 2022

AGM 22/09/2022 Newspaper Publication (As Per BSE Announcement Dated on 31/08/2022) Proceedings of the 50th Annual General Meeting held on Thursday, September 22, 2022 Appointment and Re-appointment in Annual General Meeting dt 22-09-2022 (As Per BSE Announcement Dated on 22.09.2022) Outcome of 50th Annual General Meeting of Kilpest India Limited held on Thursday, September 22, 2022 Scrutinizer''s Report of the 50th Annual General Meeting of Kilpest India Limited held on Thursday, September 22, 2022 (As per BSE Announcement Dated on 23/9/2022)

AGM Date: 22 Sep 2023

Public Notice for 51st Annual General Meeting of the company Record Date and Date of Book Closure for the purpose of Dividend and AGM Notice of 51st Annual General Meeting to be held on 22nd September,2023 Dividend updates Pursuant to the provisions of Regulation 34 of the SEBI (LODR) Regulations, 2015, please find enclosed herewith the Annual Report of the Company for the Financial Year 2022-23. (As Per BSE Announcement Dated on 29/08/2023) Proceedings of the 51st Annual General Meeting of the Company held today i.e. 22nd September, 2023 at 11:30 AM (As Per BSE Announcement Dated on 22/09/2023) Voting Results and Scrutinizer''s report for 51st Annual General Meeting Re-appointment of Director in 51st Annual General Meeting (As per BSE Announcement Dated on 23/09/2023)

AGM Date: 24 Sep 2024

AGM 24/09/2024 Outcome of AGM (As Per BSE Announcement Dated on 24.09.2024) Appointment/Re-Appointment of Directors (As Per BSE Announcement Dated on 25.09.2024)

AGM Date: 26 Sep 2025

AGM 26/09/2025 Newspaper Advertisement (As per BSE Announcement Dated on 03.09.2025) Outcome of AGM (As Per Bse Announcement dated on 26/09/2025) Scrutinizer''S Report (As per BSE Announcement dated on: 27/09/2025)

EGM Date: 16 Feb 2021

Board of Directors of the Company at their meeting held today, at 1:00 PM ,have approved the appointment of Mr. Dhirendra Dubey (DIN: 01493040) as Chairman cum Managing Director of M/s Kilpest India Limited. He shall hold the office as Chairman cum Managing Director of M/s Kilpest India Limited for a period of 5 years Subject to the approval of shareholders vide Extra-Ordinary General Meeting of the Company to be held on Tuesday, February 16, 2021 at 11:30 AM EGM convened on Tuesday , 16th February , 2021 at 11:30 A.M. at its Registered Office to appoint Shri. Dhirendra Dubey as Chairman cum Managing Director of the Company. (As Per BSE Announcement dated on 19.01.2021) PROCEEDINGS OF THE EXTRA-ORDINARY GENERAL MEETING (As Per BSE Announcement Dated on 2/16/2021 1:04:14 PM) Disclosure of voting results of EGM SUBMISSION OF SCRUTINIZER'S REPORT (As Per BSE Announcement dated on 17.02.2021) Kilpest India Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As per BSE Announcement Dated on 18/2/2021)

EGM Date: 05 Aug 2022

COM 05/08/2022 Amalgamation of 3B Blackbio Biotech India Limited, Subsidiary Company ('Transferor Company')and Kilpest India Limited, Holding''Company ('Transferee Company'). (As Per BSE Announcement dated on 26.07.2022)

EGM Date: 02 Nov 2022

COM 02/11/2022 Amalgamation of 3B Blackbio Biotech India Limited, Subsidiary Company ('Transferor Company') and Kilpest India Limited, Holding Company ('Transferee Company'). (As Per BSE Announcement dated on 16.09.2022) Notice of the meeting of the Equity Shareholders of Kilpest India Limited ('Transferee Company') to be convened in accordance with the order of the Hon'ble National Company Law Tribunal, Indore Bench. (As Per BSE Announcement Dated on 29/09/2022) Proceedings of the Meeting of Shareholders of the Company held on 2nd November, 2022 - NCLT Convened Meeting. Proceedings of the Meeting of Unsecured Creditors of the Company held on 2nd November, 2022 - NCLT Convened Meeting. (As Per BSE Announcement Dated on 02/11/2022) Declaration of Voting Results in respect of Resolution Passed at the NCLT Convened Meeting of Equity Shareholders of Company held on Wednesday, 2nd November, 2022 At 11:30 a.m. Through Video Conferencing (''VC'') / Other Audio Visual Means (''OAVM''). Declaration of Voting Results in respect of Resolution Passed at the NCLT Convened Meeting of Unsecured Creditors of Company held on Wednesday, 2nd November, 2022 At 12 Noon through Video Conferencing (''''VC'''') / Other Audio Visual Means (''''OAVM''''). (As per BSE Announcement Dated on 03/11/2022)

3B Blackbio DX Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Max Healthcare Institute Ltd	₹1,121.90	₹1,09,099.45
Apollo Hospitals Enterprise Ltd	₹7,488.40	₹1,07,671.70
Fortis Healthcare Ltd	₹944.15	₹71,279.37
Narayana Hrudayalaya Ltd	₹2,027.90	₹41,442.33
Aster DM Healthcare Ltd	₹678.35	₹35,146.74

3B Blackbio DX Ltd Top Mutal Funds Invested

Fund Name	AUM
Bandhan BSE Healthcare Index Fund	0.05%

3B Blackbio DX Ltd News

3B Blackbio DX to table results

On 13 November 2025

07 Nov 2025, 04:03 pm

3B Blackbio DX schedules AGM

On 26 September 2025

05 Sep 2025, 03:28 pm

3D Blackbio DX to convene board meeting

On 14 August 2025

08 Aug 2025, 10:40 am

3B BlackBio Dx announces demise of director

On 13 July 2025

15 Jul 2025, 02:14 pm

3B Blackbio DX Ltd leads losers in 'B' group

Denta Water & Infra Solutions Ltd, Delta Manufacturing Ltd, Alpa Laboratories Ltd and Ashoka Metcast Ltd are among the other losers in the BSE's 'B' group today, 29 May 2025.

29 May 2025, 02:45 pm

3B Blackbio DX Ltd Stock Analysis

Annual revenue for 3B Blackbio DX Ltd increased by 27.11% to ₹105.56 crore in FY 2025 from ₹83.04 crore in FY 2024.
Annual Net Profit for 3B Blackbio DX Ltd increased by 39.01% to ₹47.56 crore in FY 2025 from ₹34.21 crore in FY 2024.
Promoter Shareholding in 3B Blackbio DX Ltd remains unchanged by 0.00% in the most recent quarter, from 41.28% in June 2025 to 41.28% in September 2025.
3B Blackbio DX Ltd delivered a 1-year return of -20.96% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
3B Blackbio DX Ltd share price moved up by 0.88% from its previous close of INR ₹1,328.15. The latest 3B Blackbio DX Ltd share price is INR ₹1,339.85.
3B Blackbio DX Ltd share price today has been at a low of 1,316.40 and a high of 1,359. Over the past 52 weeks, the 3B Blackbio DX Ltd share price has seen a low of 1,248 and a high of 2,350.